A Prospective, Multicenter, Non-interventional, Real-world Study to Characterize Changes in Molecular Markers After Three Weeks of Targeted Therapy With Oxitinib in EGFRm NSCLC
Conditions
- Non Small Cell Lung Cancer
Sponsor
Beijing Cancer Prevention & Treatment Society
Collaborators